These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37955624)

  • 21. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients.
    Toniutto P; Falleti E; Cmet S; Cussigh A; Veneto L; Bitetto D; Fornasiere E; Fumolo E; Fabris C; Sartor A; Peressutti R; Curcio F; Regattin L; Grillone L
    J Hepatol; 2022 Jul; 77(1):152-162. PubMed ID: 35283215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
    Reindl-Schwaighofer R; Heinzel A; Mayrdorfer M; Jabbour R; Hofbauer TM; Merrelaar A; Eder M; Regele F; Doberer K; Spechtl P; Aschauer C; Koblischke M; Paschen C; Eskandary F; Hu K; Öhler B; Bhandal A; Kleibenböck S; Jagoditsch RI; Reiskopf B; Heger F; Bond G; Böhmig GA; Strassl R; Weseslindtner L; Indra A; Aberle JH; Binder M; Oberbauer R
    JAMA Intern Med; 2022 Feb; 182(2):165-171. PubMed ID: 34928302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between a low response to rubella vaccination and reduced anti-severe acute respiratory syndrome coronavirus 2 immune response after vaccination with BNT162b2: a cross-sectional study.
    Nakaharai K; Nakazawa Y; Mishima Y; Saito M; Shinozaki Y; Yoshida M
    Clin Microbiol Infect; 2023 Feb; 29(2):253.e1-253.e5. PubMed ID: 36150670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinations.
    Meredith RT; Bermingham MD; Bentley K; Agah S; Aboagye-Odei A; Yarham RAR; Mills H; Shaikh M; Hoye N; Stanton RJ; Chadwick DR; Oliver MA
    Front Cell Infect Microbiol; 2023; 13():1207313. PubMed ID: 37424787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma.
    Suzuki T; Kusumoto S; Kamezaki Y; Hashimoto H; Nishitarumizu N; Nakanishi Y; Kato Y; Kawai A; Matsunaga N; Ebina T; Nakamura T; Marumo Y; Oiwa K; Kinoshita S; Narita T; Ito A; Inagaki A; Ri M; Komatsu H; Aritsu T; Iida S
    Int J Hematol; 2023 Jun; 117(6):900-909. PubMed ID: 36790667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients.
    Luxenburger H; Reeg DB; Lang-Meli J; Reinscheid M; Eisner M; Bettinger D; Oberhardt V; Salimi Alizei E; Wild K; Graeser A; Karl V; Sagar ; Emmerich F; Klein F; Panning M; Huzly D; Bengsch B; Boettler T; Elling R; Thimme R; Hofmann M; Neumann-Haefelin C
    J Hepatol; 2023 May; 78(5):1017-1027. PubMed ID: 36804404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.
    Hoffman TW; Meek B; Rijkers GT; van Kessel DA
    Transpl Immunol; 2022 Jun; 72():101599. PubMed ID: 35390480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients.
    D'Offizi G; Agrati C; Visco-Comandini U; Castilletti C; Puro V; Piccolo P; Montalbano M; Meschi S; Tartaglia E; Sorace C; Leone S; Lapa D; Grassi G; Goletti D; Ippolito G; Vaia F; Ettorre GM; Lionetti R
    Liver Int; 2022 Jan; 42(1):180-186. PubMed ID: 34719107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
    Danthu C; Hantz S; Dahlem A; Duval M; Ba B; Guibbert M; El Ouafi Z; Ponsard S; Berrahal I; Achard JM; Bocquentin F; Allot V; Rerolle JP; Alain S; Touré F
    J Am Soc Nephrol; 2021 Sep; 32(9):2153-2158. PubMed ID: 34135083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-month humoral response following two or three doses of messenger RNA coronavirus disease 2019 vaccines as primary vaccination in specific populations in France: first results from the Agence Nationale Recherche contre le Sida (ANRS)0001S COV-POPART cohort.
    Loubet P; Wittkop L; Ninove L; Chalouni M; Barrou B; Blay JY; Hourmant M; Thouvenot E; Laville M; Laviolle B; Lelievre JD; Morel J; Quoc SN; Spano JP; Terrier B; Thiebaut A; Viallard JF; Vrtovsnik F; Circosta S; Esterle L; Levier A; Vanhems P; Tartour E; Parfait B; de Lamballerie X; Launay O;
    Clin Microbiol Infect; 2023 Mar; 29(3):388.e1-388.e8. PubMed ID: 36252789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between Low Anti-spike Antibody Levels After the Third Dose of SARS-CoV-2 Vaccination and Hospitalization due to Symptomatic Breakthrough Infection in Kidney Transplant Recipients.
    Han A; Min S; Jo EA; Lee H; Kim YC; Han SS; Kang HG; Ahn YH; Oh I; Song EY; Ha J
    Ann Lab Med; 2024 Jan; 44(1):64-73. PubMed ID: 37665287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients.
    Huang HJ; Yi SG; Mobley CM; Saharia A; Bhimaraj A; Moore LW; Kloc M; Adrogue HE; Graviss EA; Nguyen DT; Eagar TN; Jones SL; Ankoma-Sey V; MacGillivray TE; Knight RJ; Gaber AO; Ghobrial RM
    Clin Transplant; 2022 May; 36(5):e14600. PubMed ID: 35083796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine.
    Yang J; Lee KW; Baek JY; Bae S; Lee YH; Kim H; Huh K; Cho SY; Kang CI; Chung DR; Peck KR; Park JB; Kim SH; Kim TJ; Kim DM; Ko JH
    Am J Transplant; 2023 Apr; 23(4):565-572. PubMed ID: 36739177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic.
    Reischig T; Kacer M; Vlas T; Drenko P; Kielberger L; Machova J; Topolcan O; Kucera R; Kormunda S
    Am J Transplant; 2022 Mar; 22(3):801-812. PubMed ID: 34860470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric solid organ transplant recipients demonstrate robust cell-mediated and humoral responses to three doses of mRNA SARS-CoV-2 vaccine.
    Bratic JS; Gans HA; Chen SF; Banaei N; Johnston EM; Sear K; Samreth S; Nadimpalli SS
    Am J Transplant; 2022 Dec; 22(12):3047-3052. PubMed ID: 36083190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral response to heterologous prime-booster vaccination in heart transplant recipients aged 18-70 years primed with a viral vector SARS-CoV-2 vaccine.
    Tanner R; Starr N; Perez-Garcia CN; Chan G; Dempsey E; Heffernan E; Lynch B; Hannan MM; Joyce E
    Transpl Infect Dis; 2022 Dec; 24(6):e13935. PubMed ID: 35980217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 vaccine alleviates disease burden and severity in liver transplant recipients even with low antibody titers.
    Khalaileh A; Imam A; Jammal A; Hakimian D; Amer J; Shafrir A; Milgrom Y; Massarwa M; Hazou W; Khader M; Safadi R
    Hepatol Commun; 2023 Feb; 7(2):e0025. PubMed ID: 36724131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine.
    Grupper A; Katchman E; Ben-Yehoyada M; Rabinowich L; Schwartz D; Schwartz IF; Shashar M; Halperin T; Turner D; Goykhman Y; Shibolet O; Levy S; Houri I; Baruch R; Katchman H
    Clin Transplant; 2021 Dec; 35(12):e14478. PubMed ID: 34506644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.